SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4bv1'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQE_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)
4bv1 NEQ011
(Nanoarchaeum
equitans)
4 / 4 HIS A  41
HIS A 100
HIS A  10
HIS A  35
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
1.33A 2fqeA-4bv1A:
undetectable
2fqeA-4bv1A:
11.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQG_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)
4bv1 NEQ011
(Nanoarchaeum
equitans)
4 / 4 HIS A  10
HIS A  35
HIS A  41
HIS A 100
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
1.35A 2fqgA-4bv1A:
undetectable
2fqgA-4bv1A:
11.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQG_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)
4bv1 NEQ011
(Nanoarchaeum
equitans)
4 / 4 HIS A  35
HIS A  10
HIS A 100
HIS A  41
FE  A 120 (-3.4A)
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
FE  A 120 (-3.5A)
1.34A 2fqgA-4bv1A:
undetectable
2fqgA-4bv1A:
11.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1004_0
(BLUE COPPER OXIDASE
CUEO)
4bv1 NEQ011
(Nanoarchaeum
equitans)
4 / 4 HIS A  10
HIS A  35
HIS A  41
HIS A 100
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
1.36A 4ef3A-4bv1A:
undetectable
4ef3A-4bv1A:
11.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1004_0
(BLUE COPPER OXIDASE
CUEO)
4bv1 NEQ011
(Nanoarchaeum
equitans)
4 / 4 HIS A  35
HIS A  10
HIS A 100
HIS A  41
FE  A 120 (-3.4A)
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
FE  A 120 (-3.5A)
1.36A 4ef3A-4bv1A:
undetectable
4ef3A-4bv1A:
11.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MHU_A_CUA503_0
(LACCASE 2)
4bv1 NEQ011
(Nanoarchaeum
equitans)
4 / 4 HIS A  10
HIS A  35
HIS A  41
HIS A 100
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
1.32A 5mhuA-4bv1A:
undetectable
5mhuA-4bv1A:
11.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MI2_A_CUA603_0
(LACCASE 2)
4bv1 NEQ011
(Nanoarchaeum
equitans)
4 / 4 HIS A  41
HIS A 100
HIS A  10
HIS A  35
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
1.25A 5mi2A-4bv1A:
undetectable
5mi2A-4bv1A:
9.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MIA_A_CUA603_0
(LACCASE 2)
4bv1 NEQ011
(Nanoarchaeum
equitans)
4 / 4 HIS A  41
HIS A 100
HIS A  10
HIS A  35
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
1.25A 5miaA-4bv1A:
undetectable
5miaA-4bv1A:
9.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MIB_A_CUA603_0
(LACCASE 2)
4bv1 NEQ011
(Nanoarchaeum
equitans)
4 / 4 HIS A  41
HIS A 100
HIS A  10
HIS A  35
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
1.25A 5mibA-4bv1A:
undetectable
5mibA-4bv1A:
9.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MIC_A_CUA603_0
(LACCASE 2)
4bv1 NEQ011
(Nanoarchaeum
equitans)
4 / 4 HIS A  41
HIS A 100
HIS A  10
HIS A  35
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
1.25A 5micA-4bv1A:
undetectable
5micA-4bv1A:
9.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MID_A_CUA603_0
(LACCASE 2)
4bv1 NEQ011
(Nanoarchaeum
equitans)
4 / 4 HIS A  41
HIS A 100
HIS A  10
HIS A  35
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
1.25A 5midA-4bv1A:
undetectable
5midA-4bv1A:
9.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MIE_A_CUA603_0
(LACCASE 2)
4bv1 NEQ011
(Nanoarchaeum
equitans)
4 / 4 HIS A  41
HIS A 100
HIS A  10
HIS A  35
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
1.25A 5mieA-4bv1A:
undetectable
5mieA-4bv1A:
9.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MIG_A_CUA603_0
(LACCASE 2)
4bv1 NEQ011
(Nanoarchaeum
equitans)
4 / 4 HIS A  41
HIS A 100
HIS A  10
HIS A  35
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
1.24A 5migA-4bv1A:
2.3
5migA-4bv1A:
9.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y9Y_A_ACTA409_0
(UNCHARACTERIZED
PROTEIN KDOO)
4bv1 NEQ011
(Nanoarchaeum
equitans)
3 / 3 LYS A  78
PRO A  77
LYS A  34
None
1.31A 5y9yA-4bv1A:
undetectable
5y9yA-4bv1A:
17.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZRD_A_CUA606_0
(TYROSINASE)
4bv1 NEQ011
(Nanoarchaeum
equitans)
4 / 4 HIS A  10
CYH A  97
HIS A  41
HIS A  35
FE  A 120 (-3.5A)
FE  A 120 (-2.5A)
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
1.26A 5zrdA-4bv1A:
undetectable
5zrdA-4bv1A:
11.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZRD_A_CUA606_0
(TYROSINASE)
4bv1 NEQ011
(Nanoarchaeum
equitans)
4 / 4 HIS A 100
CYH A  97
HIS A  41
HIS A  35
FE  A 120 (-3.4A)
FE  A 120 (-2.5A)
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
1.34A 5zrdA-4bv1A:
undetectable
5zrdA-4bv1A:
11.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZRD_D_CUD606_0
(TYROSINASE)
4bv1 NEQ011
(Nanoarchaeum
equitans)
4 / 5 HIS A  10
CYH A  97
HIS A  41
HIS A  35
FE  A 120 (-3.5A)
FE  A 120 (-2.5A)
FE  A 120 (-3.5A)
FE  A 120 (-3.4A)
1.24A 5zrdD-4bv1A:
3.5
5zrdD-4bv1A:
11.50